Russell Basser
Director/Board Member at STARPHARMA HOLDINGS LIMITED
Profile
Russell Basser is currently a Director at Medical Developments International Ltd., an Independent Non-Executive Director at Starpharma Holdings Ltd., and the Chief Medical Officer at CSL Ltd.
(United States).
Previously, he worked at CSL Behring LLC as the Senior VP-Global Clinical Research & Development from 2014 to 2022.
Basser received his undergraduate and doctorate degrees from the University of Melbourne.
Russell Basser active positions
| Companies | Position | Start |
|---|---|---|
| STARPHARMA HOLDINGS LIMITED | Director/Board Member | 2023-02-19 |
| MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED | Director/Board Member | 2023-08-31 |
| CSL Ltd. (United States) | Chief Tech/Sci/R&D Officer | - |
Former positions of Russell Basser
| Companies | Position | End |
|---|---|---|
CSL Behring LLC
 CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | Chief Tech/Sci/R&D Officer | 2022-03-31 |
Training of Russell Basser
| University of Melbourne | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED | Health Technology |
| STARPHARMA HOLDINGS LIMITED | Health Technology |
| Private companies | 2 |
|---|---|
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | Health Technology |
| CSL Ltd. (United States) |
- Stock Market
- Insiders
- Russell Basser
